BRPI0815565A2 - Composições de esterol 24-c-metiltransferase de leishmania para a prevenção, tratamento e diagnóstico de leishmaniose. - Google Patents
Composições de esterol 24-c-metiltransferase de leishmania para a prevenção, tratamento e diagnóstico de leishmaniose.Info
- Publication number
- BRPI0815565A2 BRPI0815565A2 BRPI0815565-8A2A BRPI0815565A BRPI0815565A2 BR PI0815565 A2 BRPI0815565 A2 BR PI0815565A2 BR PI0815565 A BRPI0815565 A BR PI0815565A BR PI0815565 A2 BRPI0815565 A2 BR PI0815565A2
- Authority
- BR
- Brazil
- Prior art keywords
- leishmaniasis
- methyltransferase
- diagnosis
- prevention
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94963707P | 2007-07-13 | 2007-07-13 | |
PCT/US2008/069843 WO2009012166A1 (en) | 2007-07-13 | 2008-07-11 | Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815565A2 true BRPI0815565A2 (pt) | 2015-02-18 |
Family
ID=39760688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815565-8A2A BRPI0815565A2 (pt) | 2007-07-13 | 2008-07-11 | Composições de esterol 24-c-metiltransferase de leishmania para a prevenção, tratamento e diagnóstico de leishmaniose. |
Country Status (7)
Country | Link |
---|---|
US (1) | US8916168B2 (pt) |
EP (1) | EP2170372A1 (pt) |
CN (1) | CN101743016B (pt) |
BR (1) | BRPI0815565A2 (pt) |
EA (1) | EA017958B1 (pt) |
HK (1) | HK1144915A1 (pt) |
WO (1) | WO2009012166A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7833534B2 (en) | 2006-04-10 | 2010-11-16 | Infectious Disease Research Institute | Compounds and methods for diagnosis and treatment of leishmaniasis |
US8410258B2 (en) | 2008-05-21 | 2013-04-02 | Infections Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
EP2300051B1 (en) * | 2008-05-21 | 2014-11-12 | Infectious Disease Research Institute | Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
ES2628743T3 (es) | 2008-07-03 | 2017-08-03 | Infectious Disease Research Institute | Proteínas de fusión y su uso en el diagnóstico y tratamiento de la leishmaniasis |
ES2352780B2 (es) * | 2009-06-04 | 2011-09-15 | Laboratorios Ovejero S.A. | Lipopolisacárido de ochrobactrum intermedium contra la sepsis. |
SA110310855B1 (ar) * | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
WO2012064659A1 (en) * | 2010-11-08 | 2012-05-18 | Infectious Disease Research Institute | Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis |
BR112015024860B1 (pt) | 2013-03-28 | 2023-11-07 | Access To Advanced Health Institute | Polipeptídeo de fusão, polinucleotídeo isolado, composição compreendendo dito polipeptídeo, uso da dita composição para estimular uma resposta imune contra leishmania e método in vitro e kit de diagnóstico para detectar infecção por leishmania em uma amostra biológica |
US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
US9017698B2 (en) | 2013-09-25 | 2015-04-28 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
EA201691348A1 (ru) | 2013-12-31 | 2016-11-30 | Инфекшес Дизиз Рисерч Инститьют | Однофлаконные вакцинные составы |
MX2018014399A (es) | 2016-06-01 | 2019-06-06 | Infectious Disease Res Inst | Particulas de nanoalumbre que contienen un agente de dimensionamiento. |
CA3141577A1 (en) | 2019-05-25 | 2020-12-03 | Infectious Disease Research Institute | Composition and method for spray drying an adjuvant vaccine emulsion |
US20240050561A1 (en) | 2020-12-23 | 2024-02-15 | Access To Advanced Health Institute | Solanesol vaccine adjuvants and methods of preparing same |
CN114250206B (zh) * | 2021-12-25 | 2024-03-19 | 苏州瀚源新酶生物科技有限公司 | 甲基转移酶突变体、重组载体、重组工程菌及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500437B1 (en) * | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
-
2008
- 2008-07-11 EP EP08781725A patent/EP2170372A1/en not_active Withdrawn
- 2008-07-11 WO PCT/US2008/069843 patent/WO2009012166A1/en active Application Filing
- 2008-07-11 CN CN200880024553.3A patent/CN101743016B/zh not_active Expired - Fee Related
- 2008-07-11 US US12/171,729 patent/US8916168B2/en active Active
- 2008-07-11 BR BRPI0815565-8A2A patent/BRPI0815565A2/pt not_active Application Discontinuation
- 2008-07-11 EA EA201070140A patent/EA017958B1/ru not_active IP Right Cessation
-
2010
- 2010-12-13 HK HK10111591.8A patent/HK1144915A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101743016A (zh) | 2010-06-16 |
EA201070140A1 (ru) | 2010-08-30 |
US20090041798A1 (en) | 2009-02-12 |
US8916168B2 (en) | 2014-12-23 |
CN101743016B (zh) | 2015-05-13 |
WO2009012166A1 (en) | 2009-01-22 |
HK1144915A1 (en) | 2011-03-18 |
EP2170372A1 (en) | 2010-04-07 |
EA017958B1 (ru) | 2013-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0815565A2 (pt) | Composições de esterol 24-c-metiltransferase de leishmania para a prevenção, tratamento e diagnóstico de leishmaniose. | |
CL2008000691A1 (es) | Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades. | |
BRPI0718688A2 (pt) | Composições de baixa irritação e métodos para preparar as mesmas. | |
BRPI0818732A2 (pt) | Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais. | |
BRPI0812524A2 (pt) | Amidohidrolases para a preparação de gêneros alimentícios ou estimulantes | |
BRPI0814157A2 (pt) | Composição de catalisador e processos para a preparação e uma composição de catalisador e para desalquilação de etil-benzeno | |
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI0815175A2 (pt) | Dispositivo e procedimento para o diagnóstico ou para a preparação de diagnóstico e/ou para o monitoramento da terapia de doenças inflamatórias tal como artrite reumatóide | |
BRPI0917444A2 (pt) | composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc | |
BRPI0921237A2 (pt) | métodos e composições para o tratamento de distúrbios associados ao complemento | |
HK1144390A1 (en) | Compositions for the treatment of neoplastic diseases | |
WO2008086025A3 (en) | Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity | |
FI20065388A0 (fi) | Betuliiniperäiset yhdisteet antimikrobisina aineina | |
IL194800A0 (en) | Pre-mixed, ready-to-use pharmaceutical compositions | |
ZA201004622B (en) | Method for increasing the therapeutic efficacy if curcuminoids and analogues | |
BRPI1013778A2 (pt) | "equipamento para tratamento por imersão." | |
BRPI1010617A2 (pt) | uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição. | |
BRPI0916102A2 (pt) | "método para a prevenção da hérnia paraestomal, método para preparar uma hérnia paraestomal e dispositivo para preparar ou reduzir a incidência da hérnia paraestomal" | |
BRPI0716985A2 (pt) | Composição nutricional, uso da mesma, e, suplemento nutricional para o tratamento de pacientes que sofrem de alergias a alimentos | |
IL196136A (en) | Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses | |
DE602006007631D1 (de) | Verpackung für implantierbare chirurgische Netze. | |
BRPI0807903A2 (pt) | Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno. | |
EP1941881A4 (en) | MEDIUM FOR THE TREATMENT OF DERMATITIS | |
BR112012001595A2 (pt) | Composição de suspoemulsão pesticida, método para preparação da composição de suspoemulsão pesticida, uso de uma composição de suspoemulsão, método para combater ou proteger fungos fitopatogênicos, método para tratar sementes e sementes | |
WO2009018551A3 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal: dismissal of application maintained |